CureVac

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CureVac and other ETFs, options, and stocks.

About CVAC

CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy.

CEO

Franz-Werner Haas

CEOFranz-Werner Haas

Employees

884

Employees884

Headquarters

Tübingen, Baden Wuerttemberg

HeadquartersTübingen, Baden Wuerttemberg

Founded

2000

Founded2000

Employees

884

Employees884

CVAC Key Statistics

Market cap

1.41B

Market cap1.41B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

358.25K

Average volume358.25K

High today

$7.59

High today$7.59

Low today

$6.99

Low today$6.99

Open price

$7.38

Open price$7.38

Volume

879.76K

Volume879.76K

52 Week high

$58.36

52 Week high$58.36

52 Week low

$6.99

52 Week low$6.99

Analyst ratings

44%

of 9 ratings

Buy

33.3%

Hold

44.4%

Sell

22.2%

CVAC Earnings

-$0.70

-$0.47

-$0.23

$0.00

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 17, After Hours

ActualExpected Nov 17, After Hours